Literature DB >> 15385488

Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Alaka Mullick1, Miria Elias, Serge Picard, Lucie Bourget, Orce Jovcevski, Susan Gauthier, Ashleigh Tuite, Penelope Harakidas, Craig Bihun, Bernard Massie, Philippe Gros.   

Abstract

Experimental infection of inbred mouse strains with Candida albicans provides a good model system to identify host genetic determinants that regulate onset of, response to, and ultimate outcome of disseminated candidiasis. The A/J mouse strain is exquisitely sensitive to infection with C. albicans, while the C57BL/6J strain is relatively resistant, as measured by survival following intravenous injection of Candida blastospores. This differential susceptibility is caused by an A/J-specific loss-of-function mutation in the C5 component of the complement pathway. C5 plays several critical roles in host response to infection, including target lysis and phagocyte recruitment. Therefore, to determine which of its functions were required for host resistance to candidiasis, a detailed comparative analysis of pathophysiology and host response to acute C. albicans infection was conducted in A/J and C57BL/6J mice. C5-sufficient C57BL/6J mice were found to succumb late in infection due to severe kidney pathology, typified by fungal replication and robust neutrophil-based inflammatory response associated with extensive tissue damage. In contrast, A/J mice were moribund within 24 h postinfection but displayed little if any kidney damage despite an inability to mobilize granulocytes and a high fungal load in the kidney. Rather, C5 deficiency in A/J mice was associated with higher levels of circulating cytokines tumor necrosis factor alpha, interleukin-6, monocyte chemotactic protein 1 (MCP-1), MCP-5, and eotaxin in response to C. albicans. Transfer of the C5-defective allele from A/J onto a C57BL/6J genetic background in recombinant congenic strain BcA17 recapitulated the phenotypic aspects of the susceptibility of A/J mice to C. albicans, confirming the causative role of C5 deficiency in the dysregulated cytokine response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385488      PMCID: PMC517586          DOI: 10.1128/IAI.72.10.5868-5876.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

Review 1.  Immunity to Candida albicans: Th1, Th2 cells and beyond.

Authors:  L Romani
Journal:  Curr Opin Microbiol       Date:  1999-08       Impact factor: 7.934

2.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.

Authors:  M Uguccioni; C R Mackay; B Ochensberger; P Loetscher; S Rhis; G J LaRosa; P Rao; P D Ponath; M Baggiolini; C A Dahinden
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha.

Authors:  B J Czermak; V Sarma; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

4.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1.

Authors:  L Gu; S Tseng; R M Horner; C Tam; M Loda; B J Rollins
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

5.  Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration.

Authors:  H Osaka; A McGinty; U E Höepken; B Lu; C Gerard; G M Pasinetti
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 6.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

7.  The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.

Authors:  Frank Hildebrand; Hans-Christoph Pape; Petra Hoevel; Christian Krettek; Martijn van Griensven
Journal:  Shock       Date:  2003-10       Impact factor: 3.454

8.  Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration.

Authors:  J J Campbell; E F Foxman; E C Butcher
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

9.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis.

Authors:  Ji-Jing Yan; Jun-Sub Jung; Jung-Eun Lee; Jongho Lee; Sung-Oh Huh; Hee-Sung Kim; Kyeong Cheon Jung; Jae-Young Cho; Ju-Suk Nam; Hong-Won Suh; Yung-Hi Kim; Dong-Keun Song
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

10.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

View more
  36 in total

Review 1.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

2.  TOP2 gene is involved in the pathogenicity of Candida albicans.

Authors:  Hao Zheng; Yong-Sheng Yu
Journal:  Mol Cell Biochem       Date:  2011-12-28       Impact factor: 3.396

3.  Forward genetics in Candida albicans that reveals the Arp2/3 complex is required for hyphal formation, but not endocytosis.

Authors:  Elias Epp; Andrea Walther; Guylaine Lépine; Zully Leon; Alaka Mullick; Martine Raymond; Jürgen Wendland; Malcolm Whiteway
Journal:  Mol Microbiol       Date:  2010-02-04       Impact factor: 3.501

4.  Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.

Authors:  Elias Epp; Ghyslaine Vanier; Doreen Harcus; Anna Y Lee; Gregor Jansen; Michael Hallett; Don C Sheppard; David Y Thomas; Carol A Munro; Alaka Mullick; Malcolm Whiteway
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

5.  Genome-wide mapping of the coactivator Ada2p yields insight into the functional roles of SAGA/ADA complex in Candida albicans.

Authors:  Adnane Sellam; Christopher Askew; Elias Epp; Hugo Lavoie; Malcolm Whiteway; André Nantel
Journal:  Mol Biol Cell       Date:  2009-03-11       Impact factor: 4.138

6.  Role of transcription factor CaNdt80p in cell separation, hyphal growth, and virulence in Candida albicans.

Authors:  Adnane Sellam; Christopher Askew; Elias Epp; Faiza Tebbji; Alaka Mullick; Malcolm Whiteway; André Nantel
Journal:  Eukaryot Cell       Date:  2010-01-22

7.  Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Danuta Radzioch; Serge Rivest; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

8.  Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans.

Authors:  Christopher Askew; Adnane Sellam; Elias Epp; Hervé Hogues; Alaka Mullick; André Nantel; Malcolm Whiteway
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

9.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

10.  Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.

Authors:  Donna M MacCallum; Luis Castillo; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.